Atossa Genetics to Announce Third Quarter 2013 Results on Tuesday, November 12, 2013
(firmenpresse) - SEATTLE, WA -- (Marketwired) -- 11/08/13 -- (NASDAQ: ATOS), The Breast Health Company™, today announced that it will issue financial results and corporate developments for the quarter ended September 30, 2013, following the close of market on Tuesday, November 12, 2013.
Management will host a conference call on Tuesday, November 12, 2013, at 4:45 pm Eastern Time to review financial results and corporate highlights. Following management's formal remarks, there will be a question and answer session.
To listen to the call by phone, interested parties within the U.S. should call 866-652-5200. International callers should call 412-317-6060. All callers should ask for the Atossa Genetics conference call. The conference call will also be available through a live webcast at .
A replay of the call will be available approximately one hour after the end of the call through December 12, 2013. The replay can be accessed via Atossa's website or by dialing 877-344-7529 (domestic) or 412-317-0088 (international). The replay conference ID number is 10036358.
Atossa Genetics, Inc. is focused on proprietary products and services related to breast health through the commercialization of medical devices and, through its wholly-owned subsidiary, The National Reference Laboratory for Breast Health, Inc., laboratory services and tests. For additional information, please visit .
Atossa Genetics, Inc.
Kyle Guse
CFO and General Counsel
(O) 800-351-3902
MBS Value Partners
Matthew D. Haines (Investors)
Managing Director
(O) 212-710-9686
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 08.11.2013 - 13:30 Uhr
Sprache: Deutsch
News-ID 314424
Anzahl Zeichen: 0
contact information:
Town:
SEATTLE, WA
Kategorie:
Biotech
Diese Pressemitteilung wurde bisher 257 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Atossa Genetics to Announce Third Quarter 2013 Results on Tuesday, November 12, 2013"
steht unter der journalistisch-redaktionellen Verantwortung von
Atossa Genetics Inc (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
